Incysus Therapeutics launches clinical trial for cancer treatment

Incysus Therapeutics, a local biopharmaceutical company focused on cancer immunotherapy, has treated its first patient in a Phase 1 clinical trial at the O ’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham. The therapy is geared towards those who have been diagnosed with glioblastoma, a type of cancer that appears in the brain or spinal cord.  “The advancement of this exciting program during this difficult time is due to the expertise and continued execution by a…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news